Related Experiment Video
Updated: Aug 1, 2026

06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Childhood medulloblastoma in Denmark 1960-1984. A population-based retrospective study
N Agerlin1, F Gjerris, H Brincker
1University Clinic of Neurosurgery, Rigshospitalet, Copenhagen, Denmark.
Summary
Pediatric medulloblastoma survival rates improved significantly from 1960-1984 due to advancements in treatment, but outcomes remain challenging. Further international research into multimodal therapies is recommended for better pediatric brain tumor outcomes.
Area of Science:
- Pediatric neuro-oncology
- Cancer epidemiology
- Clinical trial research
Background:
- Medulloblastoma is a frequent pediatric brain tumor, primarily affecting the cerebellum and fourth ventricle.
- This study analyzes 180 children diagnosed with posterior fossa medulloblastoma in Denmark between 1960 and 1984.
Purpose of the Study:
- To evaluate the incidence, survival rates, and prognostic factors for pediatric medulloblastoma.
- To assess treatment advancements and their impact on survival over a 25-year period.
- To identify areas for future research and improved treatment strategies.
Main Methods:
- Retrospective analysis of a cohort of 180 children diagnosed with medulloblastoma.
- Data collection on incidence, male/female ratio, and survival rates (5-year and 25-year).
- Correlation of survival rates with treatment modalities, surgical techniques, radiotherapy, and chemotherapy.
Main Results:
- Mean annual incidence of medulloblastoma was 6.4x10(-6), with a slight decrease over time.
- The 5-year survival rate increased from 8% (1960-1964) to 36% (1980-1984), with a 25-year survival of 16%.
- Preoperative CSF shunting, radical tumor removal, and complete radiotherapy were key positive prognostic factors.
Conclusions:
- Treatment for pediatric medulloblastoma has improved, but outcomes are still unsatisfactory.
- Multimodal treatment approaches, potentially including neoadjuvant chemotherapy, warrant further investigation in international prospective studies.
- Continued research is essential to enhance survival rates and quality of life for children with medulloblastoma.

